Medexus Pharmaceuticals Inc (OTCPK:MEDXF)
$ 1.509 0.124 (8.95%) Market Cap: 37.62 Mil Enterprise Value: 72.91 Mil PE Ratio: 30.18 PB Ratio: 1.17 GF Score: 69/100

Q1 2025 Medexus Pharmaceuticals Inc Earnings Call Transcript

Aug 08, 2024 / 12:00PM GMT
Release Date Price: $1.77 (+7.27%)
Operator

Greetings. Welcome to the Medexus first fiscal quarter 2025 earnings call. (Operator Instructions) Please note this conference is being recorded. I will now turn the call over to your host, Victoria Rutherford.

Ma'am, you may begin.

Victoria Rutherford
Medexus Pharmaceuticals Inc - IR Contact Officer

Thank you, and good morning, everyone. Welcome to the Medexus Pharmaceuticals first fiscal quarter 2025 earnings call. On the call this morning are Ken dâEntremont, Chief Executive Officer; and Brendan Buschman, Chief Financial Officer. If you have any questions after the conference call or would like further information about the company please contact Adelaide capital at 480-625-5772.

I would like to remind everyone that this discussion will include forward-looking information as defined in securities laws. Actual results may differ materially from historical results or results anticipated by the forward-looking information.

In addition, this discussion will also include non-GAAP measures, such as adjusted net income and loss and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot